Also, these studies demonstrated that by inhibiting the expression of ADAR1 in tumor cells, the expression and sensing of immunogenic dsRNAs (by MDA5 and PKR) is favored, reestablishing the expression of ISGs and the IFN-I response and restoring sensitivity to therapy with ICIs [37,81,82]. This evidence concerns the gene ADAR and neoplasm.